https://www.ema.europa.eu/en/medicines/human/EPAR/celsunax 2021 false false false Netherlands French English syndication feed summary of product characteristics package leaflet drug evaluation 123I-ioflupane 123I-ioflupane drug approval europe iodine ioflupane (123i) diagnostic uses of chemicals adult parkinson disease neurodegenerative diseases Neuronal loss Neuronal loss in central nervous system dementia diagnosis, differential lewy body disease alzheimer disease drugs, generic injections, intravenous radiopharmaceuticals aged drug interactions pregnancy breast feeding Female of Childbearing Potential ioflupane ioflupane nortropanes nortropanes
--- https://www.ema.europa.eu/en/medicines/human/EPAR/striascan 2019 false false false United Kingdom French English treatment outcome syndication feed summary of product characteristics package leaflet drug evaluation drug approval europe 123I-ioflupane 123I-ioflupane diagnostic uses of chemicals iodine radioisotopes iodine radioisotopes adult lewy body disease diagnosis, differential parkinson disease essential tremor Neuronal loss in central nervous system drugs, generic injections, intravenous iodine ioflupane (123i) radiopharmaceuticals radiopharmaceuticals drug interactions pregnancy breast feeding drug evaluation, preclinical ioflupane ioflupane nortropanes nortropanes
--- https://www.has-sante.fr/jcms/p_3117078/fr/striascan 2019 false false false France iodine ioflupane (123i) drugs, generic 123I-ioflupane diagnostic uses of chemicals adult parkinsonian disorders lewy body disease radiopharmaceuticals evaluation of the transparency committee ioflupane nortropanes